Cite
Torres OB, Matyas GR, Rao M, et al. Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant. NPJ Vaccines. 2017;2:13doi: 10.1038/s41541-017-0013-9.
Torres, O. B., Matyas, G. R., Rao, M., Peachman, K. K., Jalah, R., Beck, Z., Michael, N. L., Rice, K. C., Jacobson, A. E., & Alving, C. R. (2017). Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant. NPJ vaccines, 213. https://doi.org/10.1038/s41541-017-0013-9
Torres, Oscar B, et al. "Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant." NPJ vaccines vol. 2 (2017): 13. doi: https://doi.org/10.1038/s41541-017-0013-9
Torres OB, Matyas GR, Rao M, Peachman KK, Jalah R, Beck Z, Michael NL, Rice KC, Jacobson AE, Alving CR. Heroin-HIV-1 (H2) vaccine: induction of dual immunologic effects with a heroin hapten-conjugate and an HIV-1 envelope V2 peptide with liposomal lipid A as an adjuvant. NPJ Vaccines. 2017 May 02;2:13. doi: 10.1038/s41541-017-0013-9. eCollection 2017. PMID: 29263870; PMCID: PMC5604742.
Copy
Download .nbib